Since sufficient tumor infiltration by T-cells is mandatory for a successful immune checkpoint blockade59, the identification of ACTBL2-positive CD44 + /CD8 + TILs in EOC tissue might be a means to determine potential patient subgroups, being particularly prone to respond to immune therapy. The gene discussed is CD44; the disease is neoplasm.